person

Jochen H.

Country
Germany
Department
Klinik für Urologie

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
0
Sites with multiple studies

Has run more than one trial at 0 of 4 partner sites.

Specializations

Renal Cell Carcinoma

Investigation of therapeutic strategies for clear cell renal cell carcinoma and non‑clear cell variants, emphasizing targeted and immunologic interventions.

  • First‑line tyrosine‑kinase inhibition
  • Immune‑checkpoint blockade
  • Combination regimens with anti‑angiogenic agents

Emphasis on metastatic disease control, biomarker‑guided patient selection, and survival outcomes.

Prostate Cancer

Clinical focus on advanced and metastatic prostate adenocarcinoma, including castration‑resistant disease and post‑surgical recurrence.

  • Androgen‑receptor signaling inhibitors
  • PSMA‑targeted radioligand therapy
  • Combination with novel hormonal agents

Prioritizes treatment sequencing, resistance mechanisms, and quality‑of‑life endpoints.

Urothelial Carcinoma

Evaluation of therapeutic options for urothelial carcinoma of the bladder and upper urinary tract, with attention to both ICI‑naïve and ICI‑experienced populations.

  • Immune‑checkpoint inhibitors
  • Enfortumab‑vedotin based regimens
  • FGFR‑targeted agents

Focus on disease‑free survival, response durability, and molecular profiling.

Kidney Transplantation & Acute Kidney Injury

Research on graft function preservation and management of acute kidney injury in transplant recipients and high‑risk cardiac surgery patients.

  • Prevention of delayed graft function
  • Biomarker‑guided renal protection strategies
  • Optimization of immunosuppressive regimens

Addresses renal recovery, long‑term graft survival, and postoperative renal risk reduction.

Renal Amyloidosis

Study of systemic AL amyloidosis with renal involvement, aiming to improve organ response and patient outcomes.

  • Light‑chain directed therapies
  • Renal function monitoring protocols
  • Integration of cardiac and renal amyloid assessment

Targets reduction of proteinuria, preservation of glomerular filtration, and multidisciplinary care pathways.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.